Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series

Track

Insider profile

Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series's trades of Minerva Neurosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-31 2026-03-31
PrS Proposed sale
9,566
88.98
US$4,486,550 		9,566 88.98 US$4,486,550
2026-03-31 2026-03-31
PrS Proposed sale
92,126
97.69
US$2,893,601 		92,126 97.69 US$2,893,601
2026-03-10 2026-03-10
PrS Proposed sale
3,074
480.41
US$4,406,452 		3,074 480.41 US$4,406,452
2024-12-18 2024-12-18
US SCYNEXIS Inc (SCYX)
PrS Proposed sale
4,709
1.23
US$5,792 		4,709 1.23 US$5,792
2024-12-18 2024-12-18
US SCYNEXIS Inc (SCYX)
PrS Proposed sale
4,709
1.23
US$5,792 		4,709 1.23 US$5,792
2024-12-11 2024-12-11
US SCYNEXIS Inc (SCYX)
PrS Proposed sale
10,988
1.23
US$13,515 		10,988 1.23 US$13,515
2024-08-27 2024-08-22
US SCYNEXIS Inc (SCYX)
PrS Proposed sale
9,700
1.77
US$17,169 		9,700 1.77 US$17,169
2024-08-22 2024-08-22
US SCYNEXIS Inc (SCYX)
PrS Proposed sale
9,700
1.77
US$17,169 		9,700 1.77 US$17,169
2023-09-22 2023-09-21
US SCYNEXIS Inc (SCYX)
PrS Proposed sale
9,214
3.42
US$31,539 		9,214 3.42 US$31,539